Auto Sector
Tata Motors upgrades existing cars
Tata Motors on Wednesday launched eight upgrades of existing models, including a CNG-fuelled version of Nano, but said little about plans for completely new vehicles to help reverse the fall in sales. Full Article
REUTERS SHOWCASE
Asian Stocks Outlook
Asian stocks to lead the way to year's end, Fed seen pulling back - Reuters Poll. Full Article
Buy, Sell or Hold?
Confused while buying stocks? Get buy, sell or hold recommendations from VantageTrade. Full Coverage
Reuters India Mobile
Get the latest news on the go. Visit Reuters India on your mobile device. Full Coverage
Sun Pharma raises FY13 sales guidance to 20-22 pct
REUTERS - Sun Pharmaceutical Industries (SUN.NS), India's top drugmaker by market value, said it has raised its sales growth guidance to 20-22 percent for the fiscal year ending March 2013.
The drugmaker had said in May sales would grow 18-20 percent in FY13.
Sun Pharma reported a 46.5 percent drop in September quarter profit to 3.2 billion rupees after it set aside 5.84 billion rupees towards a potential compensation it might have to pay in a U.S. patent dispute related to drug Protonix.
Wyeth Pharmaceuticals, a unit of Pfizer (PFE.N), has the U.S. rights to sell Protonix.
Sun Pharma said on Thursday it has sound reasons to disagree with the "overstated claims" of Wyeth. The drugmaker said it believed the patent is invalid and unenforceable and that it will pursue all available legal remedies including appeals. (Reporting by Kaustubh Kulkarni in MUMBAI; Editing by Jijo Jacob)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Follow Reuters